| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 04/15/1999 | WO1999018076A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/15/1999 | WO1998055118A3 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
| 04/15/1999 | CA2303449A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/14/1999 | EP0907644A1 Pharmaceutical preparation |
| 04/14/1999 | EP0907640A1 Substituted n-(4-pyridyl)-thioamides with pesticide activity |
| 04/14/1999 | EP0510068B1 NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS |
| 04/14/1999 | CN1213970A Method for treating autism |
| 04/14/1999 | CN1213969A Method for treating excessive aggression |
| 04/14/1999 | CN1213966A Method for treating bipolar disorder |
| 04/13/1999 | CA2045553C Process for the preparation of vinyl ethers |
| 04/08/1999 | WO1999016771A1 Condensed benzothiopyranic compounds |
| 04/08/1999 | WO1999016747A1 Sulfonyl derivatives |
| 04/08/1999 | WO1999016453A1 Method for the treatment of cystic fibrosis |
| 04/08/1999 | WO1999016313A1 2-methyl-thieno-benzodiazepine formulation |
| 04/08/1999 | WO1999016312A1 Method for treating sexual dysfunction |
| 04/08/1999 | CA2304482A1 Method for the treatment of cystic fibrosis |
| 04/08/1999 | CA2304472A1 Method for treating sexual dysfunction |
| 04/08/1999 | CA2304285A1 Sulfonyl derivatives |
| 04/08/1999 | CA2302027A1 Condensed benzothiopyranic compounds |
| 04/07/1999 | EP0632033B1 Novel benzopyran derivative |
| 04/07/1999 | CN1213373A Pyrimidin-4-one-derivatives as pesticide |
| 04/07/1999 | CN1213372A Heterocycle-condensed morphinoid derivatives (II) |
| 04/07/1999 | CN1213370A Substituted sulfonic acid N-[(aminoiminomethyl) phenylalkyl]-azaheterocyclamide compounds |
| 04/07/1999 | CN1213308A Method for treating mental drug abuse |
| 04/07/1999 | CN1212965A Process for producing hexahydrothiophene [3,4-d] imidazole-2,4-diones |
| 04/06/1999 | US5891640 Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays |
| 04/06/1999 | US5891626 Enzyme-linked analysis; using surfactant |
| 04/01/1999 | WO1999015529A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 04/01/1999 | WO1998043678B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 04/01/1999 | DE19843931A1 Production of hexa:hydro-thienoÝ3,4-d¨imidazole-2,4-dione derivatives useful as biotin intermediates |
| 03/31/1999 | EP0904083A1 Anesthetic method |
| 03/31/1999 | CN1212627A Method for treating insomnia |
| 03/30/1999 | US5889001 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 03/30/1999 | US5888992 Polar substituted hydrocarbons |
| 03/25/1999 | WO1999014203A1 Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs |
| 03/25/1999 | WO1999014202A2 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide |
| 03/25/1999 | CA2302453A1 Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs |
| 03/25/1999 | CA2301694A1 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide |
| 03/24/1999 | EP0903337A1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 03/24/1999 | CN1211985A Fused imidazole derivatives as multidrug resistance modulators |
| 03/24/1999 | CN1211920A Thieno (2,3-b) pyrazolo (3,4-d) pyridin-3-ones to enhance erythropoiesis |
| 03/23/1999 | US5886016 Benzopyranopyrazolyl derivatives for the treatment of inflammation |
| 03/23/1999 | US5886001 Agonist compounds |
| 03/23/1999 | US5885999 Treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 03/23/1999 | US5885997 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 03/23/1999 | US5885986 Cleaving, n-alkylating and reducing the intermediate formed by reacting an oxazolyl and thiazolylimidazobenzo and thienodiazepine derivatives with amine compounds; used as anxiolytic and anticonvulsant or sedative-hypnotic agents |
| 03/23/1999 | US5885936 Heterotricyclic herbicides |
| 03/23/1999 | CA2033022C Safening imidazolinone herbicides |
| 03/18/1999 | WO1999012989A1 Compounds for electronic devices |
| 03/18/1999 | WO1999012929A2 Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom |
| 03/18/1999 | WO1999012543A1 Dithiolopyrrolones and their corresponding monoxides and dioxides as antineoplastic agents |
| 03/17/1999 | EP0901489A1 Antagonists of gonadotropin releasing hormone |
| 03/17/1999 | CN1211254A Fused pyrrolo (2,3-C) carbazole-6-ones which potentiate activity of gamma interferon |
| 03/16/1999 | US5883111 Heterocyclic compounds and their use as angiotensin antagonists |
| 03/16/1999 | CA2131545C Substituted pyrimidines and their use as pesticides |
| 03/16/1999 | CA2081891C Quinolizinone type compounds |
| 03/11/1999 | WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same |
| 03/11/1999 | WO1999011647A1 Fused thiophene compounds and medicinal use thereof |
| 03/11/1999 | WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 03/11/1999 | WO1999011631A1 Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives |
| 03/11/1999 | WO1999011628A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity |
| 03/11/1999 | WO1999011624A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 03/11/1999 | CA2302409A1 Condensed thiophene compounds and pharmaceutical use thereof |
| 03/11/1999 | CA2299367A1 Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives |
| 03/11/1999 | CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 03/11/1999 | CA2294118A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 03/11/1999 | CA2294110A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity |
| 03/11/1999 | CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same |
| 03/10/1999 | EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones |
| 03/10/1999 | EP0900798A1 Fulgimide compounds, use of them, and compositions containing the same |
| 03/10/1999 | EP0900568A2 AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy |
| 03/10/1999 | EP0900223A1 Thienopyridine derivatives and their use |
| 03/10/1999 | EP0900222A1 Thienopyridine derivatives, their production and use |
| 03/10/1999 | EP0900086A1 Enhancement of sleep with a growth hormone secretagogue |
| 03/10/1999 | EP0900085A1 Method for treating excessive aggression |
| 03/10/1999 | CN1210149A Overcoming DAPA aminotransferase bottlenecks in biotin vitamers |
| 03/09/1999 | US5880270 Aminooxy-containing linker compounds for formation of stably-linked conjugates and methods related thereto |
| 03/05/1999 | CA2212237A1 Novel antineoplastic agents |
| 03/04/1999 | WO1999009984A1 Pyrrolidine and piperidine modulators of chemokine receptor activity |
| 03/04/1999 | WO1998043678A3 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 03/04/1999 | CA2298813A1 Pyrrolidine and piperidine modulators of chemokine receptor activity |
| 03/03/1999 | EP0899263A2 Fused pyrimidine derivatives and medicaments thereof for a blood oxygen partial pressure amelioration |
| 03/03/1999 | EP0898571A1 Thieno-pyridine sulfonamides, derivatives thereof and related compounds that modulate the activity of endothelin |
| 03/03/1999 | CN1209744A Vitronectin receptor antagonists |
| 03/03/1999 | CN1042328C Substituted cyclohexane derivative and medicine containing same |
| 03/02/1999 | US5877199 Heterocyclic compounds, their preparation and their therapeutic use |
| 02/25/1999 | WO1999009033A1 Thienopyridine derivatives, intermediates thereof, and process for producing the both |
| 02/25/1999 | WO1998051666A3 Process for the preparation of an oxirane, aziridine or cyclopropane |
| 02/25/1999 | CA2294853A1 Thienopyridine derivatives, intermediates thereof, and process for producing the both |
| 02/24/1999 | EP0897920A1 Novel heterocyclic compounds having platelet aggregation inhibitory effects |
| 02/24/1999 | CN1209125A Piperazine derivatives as tachykinin antagonists |
| 02/24/1999 | CN1042228C Antiallergic imidazoazepines |
| 02/23/1999 | US5874441 Carbocyclic and hetertocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents |
| 02/23/1999 | US5874179 Reacting a organophosphorus with a bi(aldehyde or ketons)organonitrogen compound |
| 02/18/1999 | WO1999007711A1 3-substituted 3,4,5,7-tetrahydro-pyrrolo3',4':4,5 thieno2,3-dpyrimidine derivatives, their preparation and use as 5ht antagonists |
| 02/18/1999 | WO1999007379A1 5,6-HETEROARYL-DIPYRIDO[2,3-b:3',2'-f]AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION |
| 02/18/1999 | CA2300391A1 3-substituted 3,4,5,7-tetrahydro-pyrrolo[3',4':4,5]thieno[2,3-d]pyrimidine derivatives |
| 02/18/1999 | CA2295620A1 5,6-heteroaryl-dipyrido¬2,3-b:3',2'-f|azepines and their use in the prevention or treatment of hiv infection |
| 02/17/1999 | CN1042133C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/16/1999 | US5872251 Process for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |